Closed
Source verified July 10, 2026
Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)
Archived vaccine research leadership initiative
Funding available
$ 300,000
Deadline
February 18, 2026
Location
Canada
Overview
Archived CIHR operating grant for Canadian mid-career researchers in vaccinology, offering up to CAD 100,000 per year for up to 3 years. It supports research on epidemic-potential infectious diseases and projects linked to CEPI or the National Research Council of Canada.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop team skills
- Conduct research and development activities
Eligible Funding
- Maximum amount : 300,000 $
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Youth (<40)
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Vaccine research and development projects
- Organ-on-chip platforms for vaccine testing
- Bioprocess innovation for vaccine production
- Preclinical, clinical, diagnostic, immunology, AI, or bioinformatics vaccine research
Documents Needed
- Tri-agency CV for all required participants
- SGBA training certificate
- Partner conflict of interest document
- Partner letter of support
- Signed signature pages
Official resources
Eligibility
Who is eligible?
- Canadian mid-career researchers
- University-affiliated researchers
- Applicants working with CEPI
- Applicants working with NRC
Who is not eligible
- Former recipients of this CIHR-CEPI vaccine leadership award
- Researchers whose primary role is outside Canada
- Applicants unable to secure CEPI or NRC as a partner
Eligible expenses
- Personnel and trainee costs
- Supplies, materials, and consumables
- Travel related to the project
- Subawardee or subcontractor costs
- Knowledge mobilization and open access publishing costs
Eligible geographic areas
- Canada
- Canadian postsecondary institutions and affiliated institutions
Selection criteria
- Clarity and strength of the research proposal
- Quality of the collaboration with the selected partner
- Feasibility of the proposed research
- Applicant’s scientific contributions and expertise
- Expected research impact and knowledge mobilization
How to apply
- Step 1: Expression of Interest
- Log in to ResearchNet.
- Identify participants and complete required profiles.
- Submit the EOI summary and select CEPI or NRC.
- Step 2: Full Application
- Co-develop the application with the selected partner.
- Complete the research proposal and budget justification.
- Upload CVs, SGBA certificates, partner documents, and attestations if required.
- Step 3: Submit in ResearchNet
- Upload signature pages and all required attachments.
- Submit the completed application before the deadline.
Processing and Agreement
- Applications are first reviewed for relevance at the Expression of Interest stage.
- Only EOI-selected applicants may submit a Full Application.
- Full Applications are then reviewed again for relevance and peer review, if applicable.
- Funding decisions are made from the top-ranked applications.
- Successful applicants are published on the CIHR website.
Additional information
- Applicants must choose one applicant partner: CEPI or NRC.
- The funding opportunity uses a two-step process: Expression of Interest and Full Application.
- A tri-agency CV is required for all participants except collaborators and sponsors.
- SGBA training certificates and a partner COI document are mandatory attachments.
Contacts
Frequently Asked Questions about the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) Program
What is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?
Archived CIHR operating grant for Canadian mid-career researchers in vaccinology, offering up to CAD 100,000 per year for up to 3 years. It supports research on epidemic-potential infectious diseases and projects linked to CEPI or the National Research Council of Canada.
How much funding can be received?
Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) Funds up to $300,000 of admissible expenses.
Who is eligible for the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program?
To be eligible for the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program, you must:
The applicant must be a mid-career independent researcher.
The applicant must have a Canadian institutional affiliation and a primary role in Canada.
The application must include CEPI or the National Research Council of Canada as the partner candidate.
What expenses are eligible under Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?
Vaccine research and development projects
Organ-on-chip platforms for vaccine testing
Bioprocess innovation for vaccine production
Preclinical, clinical, diagnostic, immunology, AI, or bioinformatics vaccine research
Who can I contact for more information about the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?
You can contact Canadian Institutes of Health Research (CIHR) by email at support-soutien@cihr-irsc.gc.ca or by phone at 613-954-1968.
Where is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) available?
The Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program is available across Canada.
Is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) a grant, loan, or tax credit?
Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) is a Grant and Funding